SBLENDORIO GLENN 4
4 · 4D Molecular Therapeutics, Inc. · Filed Jan 7, 2026
Insider Transaction Report
Form 4
SBLENDORIO GLENN
Director
Transactions
- Award
Stock Option (Right to Buy)
2026-01-05+45,000→ 45,000 totalExercise: $7.30Exp: 2036-01-04→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]One-third of the shares subject to the option vest on the first anniversary measured from January 5 2026 (the "Vesting Commencement Date"), and 1/36th of the total number of shares vest in twenty-four (24) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.